In our work, we emphasized the effects of Cul4A knockdown on lung cancer growth and increased chemosensitivity to gemcitabine, cisplatin and pemetrexed, which are a commonly used chemotherapy drugs, in lung cancer in vitro and in vivo. The gene discussed is CUL4A; the disease is lung carcinoma.